Home/Invivyd/Rachael Gerlach
RG

Rachael Gerlach

Senior Vice President of Regulatory Affairs

Invivyd

Invivyd Pipeline

DrugIndicationPhase
VYD222 (Invymab)Prevention of COVID-19Phase 3
Next-Generation COVID-19 mAbCOVID-19Preclinical/Discovery
Influenza mAb ProgramsInfluenzaDiscovery/Preclinical